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Abstract
Background/Aim. Bupivacaine (Marcaine®), homologue of mepiva-
caine, chemically related to lidocaine, is used as a local anesthetic for
local infiltration, peripheral nerve block, retrobulbar block, sym-
phathetic block, and caudal and epidural anesthesia. The aim of this
investigation was to determine and to compare clinical parameters of
the local anesthetic effects of bupivacaine applied with and without a
vasoconstrictor. Methods. This investigation included a total of 30
randomly selected patients, who ranged in age from 30−60 years, with
partial or total anodontia in the molar region of the mandible. These
patients with total or partial edentulous molar part of the mandible,
scheduled for dental implantation placement, were asked to participate
in the study. In the first phase of the investigation, the patients were
subjected to local anesthesia with 3.5 cm3 of 0.5% bupivacaine with a
vasoconstrictor (adrenalin, 1: 200 000) in the right side of the mandi-
ble. After administering local anesthesia, the placement of blade, cylin-
drical, transdental (B.C.T.) implants was performed. In the second
stage of the investigation, in 7−10 days period after the first oral sur-
gery, the patients were subjected to local anesthesia with 3.5 cm3 of
0.5% bupivacaine, but without a vasoconstrictor, in the left side of the
mandible. After administering local anesthesia, the placement of B.C.T.
implants was performed. During the performance of both oral surgery
procedures, the following clinical parameters of the local anesthetic ef-
fects were monitored: latent period, duration and the potency of an-
esthesia, and the evaluation of the postoperative pain level. Results.
The latent period under local anesthesia with 3.5 cm3 of 0.5% bupiva-
caine and vasoconstrictor was statistically significantly shorter than
without vasoconstrictor. The duration of local anesthesia was longer
without vasoconstrictor. There was no difference in the potency of an-
esthesia with or without a vasoconstrictor, while the lowest level of
postoperative pain was found after administering bupivacaine without
a vasoconstrictor use. Conclusion. The results of this investigation
show that bupivacaine without a vasoconstrictor is efficient when used
for local anesthesia in placing dental implants since it provides better
blood circulation required for good dental implant osseointegration.
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Apstrakt
Uvod/Cilj. Bupivakain (Marcaine®), homolog mepivakaina, he-
mijski srodan lidokainu, koristi se kao lokalni anestetik za lokalnu
infiltraciju, blokadu perifernog nerva, retrobulbarnu blokadu, sim-
patičku blokadu i kaudalnu i epiduralnu anesteziju. Cilj ovog istra-
živanja bio je da se utvrde i potom uporede klinički parametri efe-
kata lokalnog anestetika bupivakaina aplikovanog sa i bez vazo-
konstriktora. Metode. Istraživanje je obuhvatalo 30 bolesnika iza-
branih metodom slučajnog izbora, starosti 30−60 godina, sa deli-
mičnom ili potpunom bezubošću molarne regije mandibule. Ovi
bolesnici sa potpunom ili delimičnom bezubošću molarne regije
mandibule, koji su imali zakazane termine za ugrađivanje implan-
tata, zamoljeni su da učestvuju u studiji. U prvom delu ispitivanja
bolesnici su bili podvrgnuti lokalnoj anesteziji samo u desnu stranu
mandibule primenom 3,5 cm3 0,5% bupivakaina sa vazokonstrikto-
rom (adrenalin, 1 : 200 000). Posle davanja lokalne anestezije izvr-
šeno je plasiranje blade, cylindrical, transdental (B.C.T.) implantata. U
drugom delu ispitivanja, 7−10 dana posle prve oralne intervencije,
bolesnici su bili podvrgnuti lokalnoj anesteziji u levu stranu man-
dibule primenom 3,5 cm3 0,5% bupivakaina, ali bez vazokonstrik-
tora. Posle davanja lokalne anestezije izvršeno je plasiranje B.C.T.
implantata. Tokom izvođenja i jedne i druge oralne hirurške pro-
cedure praćeni su sledeći klinički parametri efekata lokalne aneste-
zije primenjenog bupivakaina sa i bez vazokonstriktora: latentni
period, trajanje i jačina anestezije. Takođe, izvršeno je i subjektivno
određivanje visine nivoa postoperativnog bola. Rezultati. Latentni
period kod lokalne anestezije sa 3,5 cm3 0,5% bupivakaina i vazo-
konstriktorom bio je statistički značajno kraći nego bez vazokons-
triktora, dok je  trajanje lokalne anestezije bilo duže bez dodatka
vazokonstriktora. Primena vazokonstriktora nije uticala na  jačinu
anestezije, dok je najniži nivo postoperativnog bola utvrđen posle
davanja bupivakaina bez vazokonstriktora. Zaključak. Bupivakain
bez vazokonstriktora efikasan je za lokalnu anesteziju kod plasira-
nja B.C.T. implantata pošto obezbeđuje bolju prokrvljenost neop-
hodnu za dobru oseointegraciju dentalnih implantata.
Ključne reči:
implantati, stomatološki; anestezija, lokalna;
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Introduction
Local anesthetics are the agents used to induce reversible
blocking of the perception and transmission of pain in the lim-
ited areas of the body without the loss of consciousness 
1−8.
They are capable of blocking transmission of impulse in any
excitable cell and, in so doing, influence functioning of tissue,
including sensory and motor peripheral nerves, autonomous
ganglia, central nervous system (CNS), neuromuscular syn-
apses, cardiac muscle and smooth muscles 
9−11. Local anes-
thetic solutions are the most widely used drugs in medicine
and dentistry 
12. They prevent nociception generated during
surgical and dental procedures 
13, and without them many
medical and dental procedures could not be performed 
14. Lo-
cal anesthetics are also used in diagnostics of some painful
syndromes, as well as in idiopathic trigeminal neuropathy
treatment 
15, 16. A local anesthetic solution is basically com-
posed of a local anesthetics and vasoconstrictor (most com-
monly adrenaline or noradrenaline) which raises the anesthetic
effect of a solution 
17−20. Bupivacaine, a long-acting agent, has
a special pharmacotherapeutic profile (long action, good post-
operative analgetic effect), that makes it particularly suitable
for the application in oral implantology providing better blood
circulation at the implant placement sites than other anesthet-
ics, thus ensuring better conditions for good osseointegration,
especially within the first 48 h after the placement of im-
plants 
21. Being produced in our country, makes it available for
a wide everyday use in clinical practice. Regarding bupiva-
caine, however, a number of authors think that its application
without vasoconstrictor does not meet the requirements for the
assessment of the efficacy of a local anesthetic solution 
20−22.
Oral implants placement procedures could last several hours,
during which we have to obtain effective local anesthesia and
good blood circulation at the implant placement sites. The
presence of vasoconstrictor in bupivacaine solution is impor-
tant for the achivement of effective local anesthesia, but could
compromise dental implant sites blood circulation.  Thus, the
aim of this study was to determine and, then, to compare clini-
cal parameters of the local anesthetic effects of bupivacaine
applied, firstly, with and, secondly, without the addition of a
vasoconstrictor in the placement of endosseous B.C.T. im-
plants.
Methods
The Ethical Committee in Human Research in the Mili-
tary Medical Academy, Belgrade, approved this investigation
and written consent was obtained from each of the patients.
This investigation included 30 randomly selected patients of
both sexes, who ranged in age from 30−60 years, with par-
tially or totally edentulous mandible, and all of them com-
plied with any elements of dentistry and general medicine in-
dications and contraindications. These patients, scheduled for
dental implantation placement, were asked to participate in
the study. Firstly, the patients were subjected to local anesthe-
sia with 3.5 cm
3 of 0.5% bupivacaine with a vasoconstrictor
(adrenalin, 1: 200 000) in the right side of the mandible. After
administering local anesthesia, the placement of B.C.T. im-
plants was performed. Secondly, after 7−10-day period from
the first intervention, the patients were subjected to local an-
esthesia with 3.5 cm
3 of 0.5% bupivacaine, but without a
vasoconstrictor in the left side of the mandible. After admin-
istering local anesthesia, the placement of B.C.T. implants
was performed. During the performance of both oral surgery
procedures, the clinical parameters of the local anesthetic ef-
fects were evaluated as follows: the onset of anesthesia – la-
tent period (occurrence of lower lip numbness); potency of
anesthesia during intervention graded as A (insensibility of
the lower lip and tangue), B (preassure, no pain in the implant
site region), C (moderate bearable pain in the implant site re-
gin), and D (intense pain in the implant site region requering
additional anesthesia); duration of soft tissue anesthesia – the
patients were asked to grade it according to the cessation of
soft tissue numbness; intensity of postoperative pain on a vis-
ual analog scale (VAS) questionnaire. On the 10-point VAS,
0 represented no pain, whereas 10 marked the highest score.
All the patients marked their subjective response to postop-
erative pain on a VAS (Fig. 1).
Fig.1 – Visual  analog scale (VAS) questionnaire
(0 − no pain; 10 − maximal pain intensity)
Statistical analysis was performed by determining the
following parameters: mean values, standard deviation, stan-
dard errors, statistical significance of differences in mean
values. The Student's t test and χ
2 test were used to determine
a statistical significance of the differences in mean value .
Results
The results obtained by examining the latent period af-
ter administering local anesthesia with bupivacaine with and
without vasoconstrictor are shown in Table 1.
The onset of anesthesia after applying bupivacaine
without vasoconstrictor was 6 min, while with the addition of
vasoconstrictor it was 5 min. It was statistically significantly
longer latent period in anesthesia with bupivacaine without
vasoconstrictor (6±2 : 5±2, p < 0.05).
The potency of soft tissue anesthesia after applying bu-
pivacaine with and without vasoconstrictor was good. No pain
was experienced by 14 of the patients (53%), and pressure
without pain in 12 of the patients (37%). A sense of moderate
pain was registered in 6 of the patients (20%). The data refer-
ring to the potency of anesthesia are shown in Table 2.
Statistical analysis of the obtained results for the po-
tency of anesthesia showed no significant difference in the
frequency of distribution of the potency of local anesthesia
with bupivacaine without vasoconstrictor  in regard to theo-
retical distribution, while there was a significant difference
in the frequency of distribution of the potency of local anes-
thesia with bupivacaine with vasoconstrictor in regard to
theoretical distribution (p < 0.05). However, comparison
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anesthesia with  and without vasoconstrictor did not show
any statistical significance.
The results obtained by testing the duration of local an-
esthesia after applying bupivacaine with and without vaso-
constrictor are shown in Table 3.
The duration of local anesthesia after applying bupiva-
caine with vasoconstrictor was in averrage 369 min, while it
was 440 min without the addition of vasoconstrictor. There
was no statistical difference between these values, yet they
befell in the border of statistical significance (p = 0.0779 for
the possibility of 95%).
The results of the assessment of postoperative pain (an-
algetic effect) of local anesthetic with and without vasocon-
strictor are shown in Table 4.
Table 1
Latent period in anesthesia after applying bupivacaine
with and without vasoconstrictor
Latent period (minutes)
Statistical
parameters
Bupivacaine
with
vasoconstrictor
Bupivacaine
without
vasoconstrictor
Number of patients 30                30
Mean value 5                   6
Standard deviation 2                   2
Standard error 0.30 0.28
Minimal value                  2                   3
Maximal value                   8                   9
Statistically significant com-
parisons of mean values
t = - 2.4509
p < 0.05
Table 2
The potency of local anesthesia after applying bupivacaine with and without vasoconstrictor
The potency of anesthesia Bupivacaine Total
with
vasoconstrictor
without
vasoconstrictor
n       % n % n %
A – nothing  felt     14      47     18      60    32   53
B – pressure, no pain in the
implant site region
    12      40     10      33    22   37
C – moderate bearable pain
in the implant site region
      4      13       2        7      6   10
D – intense pain in the im-
plant site region requiring
additional anesthesia
––– – – –
Total      30    100      30     100    60  100
Table 3
The duration of local anesthesia after applying bupivacaine with and without vasoconstrictor
The duration of anesthesia (minutes)
Statistical parameters Bupivacaine
with
vasoconstrictor
Bupivacaine
without
vasoconstrictor
Number of patients             30             30
Mean value            369            440
Standard deviation            167            212
Standard error              31              39
Minimal value           120            150
Maximal value            720         1 080
Significant difference in mean values t = - 1.4376
p > 0.05
Table 4
The results of the intensity of postoperative pain on a visual analog scale (VAS) questionnaire
Bupivacaine
VAS score* with
vasoconstrictor
without
vasoconstrictor
Total
n %       n        % n     %
1 19 64      23   76      42    70
2 06   20       3   10       9    15
4 04   13       2     6       6    10
5 01    3       2     6       3     5
Total 30 100      30 100      60  100
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The results obtained by the assessmenet of bupivacaine
analgetic effect show that the percentage of patients with the
lowest subjective sensation of analgetic activity was higher
with bupivacaine without vasoconstrictor (76% of the pa-
tients with the score 1 on a visual analog scale). No statisti-
cally significant differences were found between the propor-
tions of postoperative analgetic effect in anesthesia with bu-
pivacaine applied with or without vasoconstrictor.
Discussion
Regarding bupivacaine, a number of authors think that
its application without vasoconstrictor does not meet the re-
quirements for the assessment of the efficacy of a local an-
esthetic solution 
20. Oral implants placement procedures
could last several hours, during which we have to obtain ef-
fective local anesthesia and good blood circulation at the im-
plant placement sites. The presence of a vasoconstrictor in
bupivacaine solution is important for the achievement of ef-
fective local anesthesia, but could compromise dental im-
plant sites blood circulation. Bupivacaine, a long-acting
agent, has rapidly become a standard part of the instrumen-
tarium for postsurgical pain control ever since its introduc-
tion to the dental local anesthesia in 1983 
21, 22. The major
advantage of its use is the long duration of its anesthetic ef-
fect, with a very slow return to full sensation, which eases
patient through the early postoperative period 
21. Bupiva-
caine provides a significantly great duration of anesthesia,
decreased postoperative pain, and a reduction in the amount
of analgetics taken 
23, 24. Regarding addition of a vasocon-
strictor to a local anesthetic it can have both beneficial and
detrimental effects. Among the beneficial ones are: a de-
crease in the plasma peak concentration of the local anes-
thetic agent, increase in the duration and the quality of anes-
thesia, reduction of the minimum concentration of anesthetic
needed for nerve block, and decrease of blood loss during
surgical procedures. The addition of a vasoconstrictor to a
local anesthetic may also have detrimental effects, the major
among them being that it could compromise dental implant
sites blood circulation, and that it is not always optimal to
achieve the purposes for which it is added 
17. The present
study evaluated and compared local anesthesia with bupiva-
caine both with and without vasoconstrictor. The obtained
results indicated that the latent period observed for bupiva-
caine without vasoconstrictor was statistically significantly
longer (6 min 23 sec) than with it. Similar results in regard
with the duration of latent period have been obtained by
other investigators reporting even 8 min for mandibular an-
esthesia 
25.
The results obtained for the potency of local anesthesia
did not differ for both solutions. There was no need for addi-
tional anesthesia. This slightly differs from the results of
other authors 
22, 25, 26, since in our study we used 3.5 cm
3 of
0.5% local anesthetics, which could provide a sufficient
quantity of the anesthetic for mandibular anesthesia in
placement B.C.T. implants.
With respect to the duration of local anesthesia, there
was no significant difference observed between the solutions,
but it remains to note the fact that it was slightly longer
without vasoconstrictor (440±212 min). The highest percent-
age of the patients with the lowest grade for postoperative
pain was in the case of bupivacaine administered without
vasoconstrictor 
27. This speaks in favour of the wide use of
bupivacaine in oral surgery, especially for time-consuming
surgical interventions after which postoperative pain could
occur 
13, 14, 21.
Conclusion
The latent period observed for local  anesthesia with 3.5
cm
3 of 0.5% bupivacaine plus vasoconstrictor in this study
was statistically significantly shorter than that observed for
local anesthesia with the same local anesthetic but without
vasoconstrictor. The duration of  anesthesia observed for bu-
pivacaine without vasoconstrictor was longer than that ob-
served for the drug with vasoconstrictor, while there was no
difference in the potency of anesthesia regardless of whether
bupivacaine was used with or without vasoconstrictor. The
lowest score values for postoperative pain were recorded for
bupivacaine without vasoconstrictor. These findings suggest
that bupivacaine without vasoconstrictor is efficient for local
block anesthesia in placing B.C.T. implants. In this study we
also concluded that bupivacaine without a vasoconstrictor
provides better blood circulation during dental implants pla-
cement which is one of the major preconditions for better
implants osseointegration.
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